Next Article in Journal
Chitin Adsorbents for Toxic Metals: A Review
Next Article in Special Issue
Autocrine and Paracrine Mechanisms Promoting Chemoresistance in Cholangiocarcinoma
Previous Article in Journal
The Cause of Death of a Child in the 18th Century Solved by Bone Microbiome Typing Using Laser Microdissection and Next Generation Sequencing
Previous Article in Special Issue
A Systems Biological View of Life-and-Death Decision with Respect to Endoplasmic Reticulum Stress—The Role of PERK Pathway
Open AccessArticle

The Impact of Growth Hormone Therapy on the Apoptosis Assessment in CD34+ Hematopoietic Cells from Children with Growth Hormone Deficiency

1
Department of General Pathology, Pomeranian Medical University in Szczecin, 72 Powstancow Wlkp. Street, 70-111 Szczecin, Poland
2
Department of Pediatrics, Endocrinology, Diabetology, Metabolic Diseases and Cardiology of the Developmental Age, Pomeranian Medical University in Szczecin, 1 Unii Lubelskiej Street, 71-252 Szczecin, Poland
3
Department of Pediatric and Oncological Surgery, Pomeranian Medical University in Szczecin, 1 Unii Lubelskiej Street, 71-252 Szczecin, Poland
*
Author to whom correspondence should be addressed.
Academic Editor: Anthony Lemarié
Int. J. Mol. Sci. 2017, 18(1), 111; https://doi.org/10.3390/ijms18010111
Received: 18 August 2016 / Revised: 10 December 2016 / Accepted: 21 December 2016 / Published: 7 January 2017
(This article belongs to the Collection Programmed Cell Death and Apoptosis)
Growth hormone (GH) modulates hematopoietic cell homeostasis and is associated with apoptosis control, but with limited mechanistic insights. Aim of the study was to determine whether GH therapeutic supplementation (GH-TS) could affect apoptosis of CD34+ cells enriched in hematopoietic progenitor cells of GH deficient (GHD) children. CD34+ cells from peripheral blood of 40 GHD children were collected before and in 3rd and 6th month of GH-TS and compared to 60 controls adjusted for bone age, sex, and pubertal development. Next, apoptosis assessment via different molecular techniques was performed. Finally, to comprehensively characterize apoptosis process, global gene expression profile was determined using genome-wide RNA microarray technology. Results showed that GH-TS significantly reduced spontaneous apoptosis in CD34+ cells (p < 0.01) and results obtained using different methods to detect early and late apoptosis in analyzed cells population were consistent. GH-TS was also associated with significant downregulation of several members of TNF-alpha superfamily and other genes associated with apoptosis and stress response. Moreover, the significant overexpression of cyto-protective and cell cycle-associated genes was detected. These findings suggest that recombinant human GH has a direct anti-apoptotic activity in hematopoietic CD34+ cells derived from GHD subjects in course of GH-TS. View Full-Text
Keywords: CD34+ cells; hematopoietic progenitor cells; hematopoiesis; growth hormone deficiency; growth hormone deficiency in children; apoptosis; cell death; apoptosis control CD34+ cells; hematopoietic progenitor cells; hematopoiesis; growth hormone deficiency; growth hormone deficiency in children; apoptosis; cell death; apoptosis control
Show Figures

Figure 1

MDPI and ACS Style

Kawa, M.P.; Stecewicz, I.; Piecyk, K.; Paczkowska, E.; Rogińska, D.; Sobuś, A.; Łuczkowska, K.; Pius-Sadowska, E.; Gawrych, E.; Petriczko, E.; Walczak, M.; Machaliński, B. The Impact of Growth Hormone Therapy on the Apoptosis Assessment in CD34+ Hematopoietic Cells from Children with Growth Hormone Deficiency. Int. J. Mol. Sci. 2017, 18, 111.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop